All Stories

  1. Immunogenicity and Biodistribution of Anthrax DNA Vaccine Delivered by Intradermal Electroporation
  2. Enhanced Immunogenicity of Engineered HER2 Antigens Potentiates Antitumor Immune Responses
  3. The ATF6-EGF Pathway Mediates the Awakening of Slow-Cycling Chemoresistant Cells and Tumor Recurrence by Stimulating Tumor Angiogenesis
  4. Therapeutic Efficacy of ABN401, a Highly Potent and Selective MET Inhibitor, Based on Diagnostic Biomarker Test in MET-Addicted Cancer
  5. New Preclinical Development of a c-Met Inhibitor and Its Combined Anti-Tumor Effect in c-Met-Amplified NSCLC
  6. UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer
  7. Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting
  8. High expression of NR1D1 is associated with good prognosis in triple-negative breast cancer patients treated with chemotherapy
  9. Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer
  10. Development of an Equine Antitoxin by Immunizing the Halla Horse with the Receptor-Binding Domain of Botulinum Neurotoxin Type A1
  11. Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
  12. Characterization and validation of somatic mutation spectrum to reveal heterogeneity in gastric cancer by single cell sequencing
  13. A Glycoengineered Interferon-β Mutein (R27T) Generates Prolonged Signaling by an Altered Receptor-Binding Kinetics
  14. Phenotype-based discovery of a HeLa-specific cytotoxic molecule that downregulates HPV-mediated signaling pathwaysviaoxidative damage
  15. Physostigmine-loaded liposomes for extended prophylaxis against nerve agent poisoning
  16. Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patients
  17. BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer
  18. Cross-Protective Shigella Whole-Cell Vaccine With a Truncated O-Polysaccharide Chain
  19. Targeting Nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer Cells
  20. Droplet digital PCR-based EGFR mutation detection with an internal quality control index to determine the quality of DNA
  21. Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview
  22. A mutated recombinant subunit vaccine protects mice and guinea pigs against botulinum type A intoxication
  23. MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells
  24. Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans
  25. ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cellsThis article has been corrected since Advance Online Publication and an erratum is also printed in this issue
  26. Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions
  27. Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer
  28. Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancer
  29. Polyamidoamine-Decorated Nanodiamonds as a Hybrid Gene Delivery Vector and siRNA Structural Characterization at the Charged Interfaces
  30. Enhanced Cell Growth of Adipocyte-Derived Mesenchymal Stem Cells Using Chemically-Defined Serum-Free Media
  31. MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values
  32. Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients
  33. A novel staphylococcal enterotoxin B subunit vaccine candidate elicits protective immune response in a mouse model
  34. Intestinal Epithelial Cell-Specific Deletion of PLD2 Alleviates DSS-Induced Colitis by Regulating Occludin
  35. MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer
  36. A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2− early breast cancer
  37. Sensitization of glycoengineered interferon-β1a-resistant cancer cells by cFLIP inhibition for enhanced anti-cancer therapy
  38. Upregulation of SMAD4 by MZF1 inhibits migration of human gastric cancer cells
  39. LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients
  40. Essential Role of DNA Methyltransferase 1–mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors
  41. Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea
  42. Efficiency of methylated DNA immunoprecipitation bisulphite sequencing for whole-genome DNA methylation analysis
  43. Identification of diagnostic biomarkers for early detection of anthrax from human aortic endothelial cells
  44. Transducer of ERBB2.1 (TOB1) as a Tumor Suppressor: A Mechanistic Perspective
  45. Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples
  46. The potential role of PHF6 as an oncogene: a genotranscriptomic/proteomic meta-analysis
  47. STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody
  48. Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
  49. CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
  50. Basal buffer systems for a newly glycosylated recombinant human interferon-β with biophysical stability and DoE approaches
  51. Anoctamin 1 (TMEM16A) is essential for testosterone-induced prostate hyperplasia
  52. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo
  53. Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer
  54. Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer
  55. Development of an Advanced Synthetic Route to Macrosphelides and Its Application to the Discovery of a More Potent Macrosphelide Derivative
  56. SMAD4 Suppresses AURKA-Induced Metastatic Phenotypes via Degradation of AURKA in a TGF -Independent Manner
  57. Design and synthesis of a macrosphelide A-biotin chimera
  58. Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties
  59. Overexpression of Cancer-Associated Genes via Epigenetic Derepression Mechanisms in Gynecologic Cancer
  60. MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer
  61. Synthesis and Biological Evaluation of a Polyyne-Containing Sphingoid Base Probe as a Chemical Tool
  62. Prognostic significance of CD151 overexpression in non-small cell lung cancer
  63. Regulation of Ovarian Cancer Stem Cells or Tumor-Initiating Cells
  64. CD24+ ovary cancer cells exhibit an invasive mesenchymal phenotype
  65. Low SP1 Expression Differentially Affects Intestinal-Type Compared with Diffuse-Type Gastric Adenocarcinoma
  66. Human aortic endothelial cells compare favourably with macrophages for the study of anthrax toxins
  67. Long non-coding RNAs in hematologic malignancies: road to translational research
  68. Epigenetic control of metastasis-associated protein 1 gene expression by hepatitis B virus X protein during hepatocarcinogenesis
  69. Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β-catenin signaling
  70. Clinical significance of CD151 overexpression in subtypes of invasive breast cancer
  71. Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma
  72. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo
  73. A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity
  74. Cancer-Associated Splicing Variant of Tumor Suppressor AIMP2/p38: Pathological Implication in Tumorigenesis
  75. Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer
  76. Erratum to: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
  77. The potential RNAi-based combination therapeutics
  78. Merkel cell carcinoma: Our experience with seven patients in Korea and a literature review
  79. Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
  80. The Transcription Factor MIST1 Is a Novel Human Gastric Chief Cell Marker Whose Expression Is Lost in Metaplasia, Dysplasia, and Carcinoma
  81. LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast Cancer
  82. Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications
  83. A case of Hyper-IgE syndrome with a mutation of the STAT3 gene
  84. Resveratrol Suppresses Growth of Human Ovarian Cancer Cells in Culture and in a Murine Xenograft Model: Eukaryotic Elongation Factor 1A2 as a Potential Target
  85. Correction: Identification of Novel Reference Genes Using Multiplatform Expression Data and Their Validation for Quantitative Gene Expression Analysis
  86. Identification of Novel Reference Genes Using Multiplatform Expression Data and Their Validation for Quantitative Gene Expression Analysis
  87. Expression of Sonic hedgehog signaling molecules in normal, hyperplastic and carcinomatous endometrium
  88. A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-IgE syndrome
  89. Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes
  90. Inhibitory effects of oligonol on phorbol ester-induced tumor promotion and COX-2 expression in mouse skin: NF-κB and C/EBP as potential targets
  91. Magnolia officinalis Reverses Alcoholic Fatty Liver by Inhibiting the Maturation of Sterol Regulatory Element–Binding Protein-1c
  92. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma
  93. TMEM16A confers receptor-activated calcium-dependent chloride conductance
  94. Involvement of Promyelocytic Leukemia Protein in the Ethanol-induced Apoptosis in Mouse Embryo Fibroblasts
  95. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells
  96. Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients
  97. Identification of formaldehyde-responsive genes by suppression subtractive hybridization
  98. The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients
  99. Overexpression of Interleukin-10 in Sentinel Lymph Node with Breast Cancer
  100. Clinical Significance of CD99 Down-Regulation in Gastric Adenocarcinoma
  101. Inactivation of SMAD4 Tumor Suppressor Gene During Gastric Carcinoma Progression
  102. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-κB and AP-1 as prime targets
  103. Enhanced expression of hedgehog signaling molecules in squamous cell carcinoma of uterine cervix and its precursor lesions
  104. Combining multiple microarrays in the presence of controlling variables
  105. Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions
  106. TRPV1 Recapitulates Native Capsaicin Receptor in Sensory Neurons in Association with Fas-Associated Factor 1
  107. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-κB in mouse skin by blocking IκB kinase activity
  108. Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas
  109. Rapid divergency of rodent CD99 orthologs: Implications for the evolution of the pseudoautosomal region
  110. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors
  111. HUlip, a human homologue of unc-33-like phosphoprotein of Caenorhabditis elegans; Immunohistochemical localization in the developing human brain and patterns of expression in nervous system tumors
  112. Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response
  113. [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-κB in phorbol ester-stimulated mouse skin
  114. The Novel Cytokine p43 Stimulates Dermal Fibroblast Proliferation and Wound Repair
  115. The Haploinsufficient Tumor Suppressor p18 Upregulates p53 via Interactions with ATM/ATR
  116. An Immunohistochemical Study of the Expression of Adhesion Molecules in Gallbladder Lesions
  117. Targeted cytotoxic effect of anti-JL1 immunotoxin against a human leukemic cell line and its clinical implications
  118. Evaluation of Antigen Retrieval Buffer Systems
  119. Cloning, genomic organization, alternative transcripts and expression analysis of CD99L2 , a novel paralog of human CD99, and identification of evolutionary conserved motifs
  120. An Improved Protocol of Biotinylated Tyramine-based Immunohistochemistry Minimizing Nonspecific Background Staining
  121. Identification of antigenic peptide recognized by the anti-JL1 leukemia-specific monoclonal antibody from combinatorial peptide phage display libraries
  122. Expression of Leukemia-Associated Antigen, JL1, in Bone Marrow and Thymus
  123. CD99 Regulates the Transport of MHC Class I Molecules from the Golgi Complex to the Cell Surface
  124. Immature thymocyte antigen, JL1, as a possible immunodiagnostic and immunotherapeutic target for leukemia
  125. LMP1-Induced Downregulation of CD99 Molecules in Hodgkin and Reed-Sternberg Cells
  126. Viral latent membrane protein 1 (LMP-1)–induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype
  127. Reduced expression of CD99 and functional disturbance in anencephalic cortical thymocytes
  128. High CD99 expression in memory T and B cells in reactive lymph nodes
  129. Generation of Cells With Hodgkin’s and Reed-Sternberg Phenotype Through Downregulation of CD99 (Mic2)